Clinical Trial Update: Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial investigating firibastat or ramipril after acute myocardial infarction to prevent left ventricular dysfunction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Myocardial Infarction

Drugs mentioned

• Firibastat (firibastat)
• Ramipril (ramipril)

Snippet

Sponsor: Quantum Genomics SA | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2023-02-27